Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Publication of UY31649A1publicationCriticalpatent/UY31649A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
Se proporcionan ciertas entidades químicas, composiciones farmacéuticas, y métodos de tratamiento de un miembro de la familia de los flaviviradae de virus tales como el hepacivirus (Hepatitis C o HCV).Certain chemical entities, pharmaceutical compositions, and methods of treating a member of the family of virus flaviviradae such as hepacivirus (Hepatitis C or HCV) are provided.
UY31649A2008-03-312009-02-10
CERTAIN NITROGEN CONTAINING BICYCLIC CHEMICAL ENTITIES TO TREAT VIRAL INFECTIONS.
UY31649A1
(en)
Compounds derived from imidazo [1,2-f] [1,2,4] triazinyl nucleosides; pharmaceutical composition that includes them; and its use for the treatment of a flaviviridae virus infection, particularly hepatitis c virus infections.
DERIVATIVES 9-methyl substituted EXADEKAFDROKYKLOPROPA (E) pyrrolo (1,2-a) (1,4) DIAZAKYKLOPENTADEKINYL carbamate AS nonstructural 3 (NS3) PROTEASE INHIBITORS FOR THE TREATMENT OF INFECTIONS ID HEPATITIS C